{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:01:05Z","timestamp":1773662465073,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1124\/jpet.108.136226","type":"journal-article","created":{"date-parts":[[2008,2,28]],"date-time":"2008-02-28T01:46:37Z","timestamp":1204163197000},"page":"1031-1038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["5-Hydroxytryptamine Lowers Blood Pressure in Normotensive and Hypertensive Rats"],"prefix":"10.1016","volume":"325","author":[{"given":"Jessica","family":"Diaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janice","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory D.","family":"Fink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie W.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.108.136226_bib1","doi-asserted-by":"crossref","unstructured":"Amsterdam JD, Garcia-Espana F, Fawcett J, Quitkin FM, Reimherr FW, Rosenbaum JF, and Beasley C (1999) Blood pressure changes during short-term fluoxetine treatment. J Clin Psychopharm 19: 9-14.","DOI":"10.1097\/00004714-199902000-00004"},{"key":"10.1124\/jpet.108.136226_bib2","doi-asserted-by":"crossref","unstructured":"Brenner B, Harney JT, Ahmed BA, Jeffus BC, Unal R, Mehta JL, and Kilic F (2007) Plasma serotonin levels and the platelet serotonin transporter. J Neurochem 102: 206-215.","DOI":"10.1111\/j.1471-4159.2007.04542.x"},{"key":"10.1124\/jpet.108.136226_bib3","doi-asserted-by":"crossref","unstructured":"Carrasco G, Cruz MA, Gallardo V, Miguel P, Lagos M, and Gonzalez C (1998) Plasma and platelet concentration and platelet uptake of serotonin in normotensive and pre-eclamptic pregnancies. Life Sci 62: 1323-1332.","DOI":"10.1016\/S0024-3205(98)00066-6"},{"key":"10.1124\/jpet.108.136226_bib4","doi-asserted-by":"crossref","unstructured":"Chapman ME and Wideman RF (2002) Hemodynamic responses of broiler pulmonary vasculature to intravenously infused serotonin. Poultry Sci 81: 231-238.","DOI":"10.1093\/ps\/81.2.231"},{"key":"10.1124\/jpet.108.136226_bib5","doi-asserted-by":"crossref","unstructured":"C\u00f4t\u00e9 F, Fligny C, Fromes Y, Mallet J, and Vodjdani G (2004) Recent advances in understanding serotonin regulation of cardiovascular function. Trends Mol Med 10: 232-238.","DOI":"10.1016\/j.molmed.2004.03.007"},{"key":"10.1124\/jpet.108.136226_bib6","doi-asserted-by":"crossref","unstructured":"De Vries P, De Visser PA, Heiligers JPC, Villal\u00f3n CM, and Saxena PR (1999) Changes in systemic and regional haemodynamics during 5-HT7 receptor mediated depressor responses in rats. Naunyn Schmiedebergs Arch Pharmacol 359: 331-338.","DOI":"10.1007\/PL00005359"},{"key":"10.1124\/jpet.108.136226_bib7","doi-asserted-by":"crossref","unstructured":"Ekas RD and Lokhandwala MF (1980) Sympathetic nerve function and vascular reactivity in DOCA-salt hypertensive rats. Am J Physiol Regul Integr Comp Physiol 239: R303-R308.","DOI":"10.1152\/ajpregu.1980.239.3.R303"},{"key":"10.1124\/jpet.108.136226_bib8","doi-asserted-by":"crossref","unstructured":"Ellis ES, Byrne C, Murphy OE, Tilford NS, and Baxter GS (1995) Mediation of 5-hydroxytryptamine2B receptors of endothelium-dependent relaxation in rat jugular vein. Br J Pharmacol 114: 400-404.","DOI":"10.1111\/j.1476-5381.1995.tb13240.x"},{"key":"10.1124\/jpet.108.136226_bib9","doi-asserted-by":"crossref","unstructured":"Emerson TE (1968) Effects of acetylcholine, histamine, and serotonin infusion on venous return in dogs. Am J Physiol 215: 41-48.","DOI":"10.1152\/ajplegacy.1968.215.1.41"},{"key":"10.1124\/jpet.108.136226_bib10","doi-asserted-by":"crossref","unstructured":"Erspamer V and Asero B (1952) Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine. Nature 169: 800-801.","DOI":"10.1038\/169800b0"},{"key":"10.1124\/jpet.108.136226_bib11","doi-asserted-by":"crossref","unstructured":"Fetkovska N, Pletscher A, Ferracin F, Amstein R, and Buhler FR (1990) Impaired uptake of 5-hydroxytryptamine in platelet in essential hypertension: clinical relevance. Cardiovasc Drugs Ther 4: 105-109.","DOI":"10.1007\/BF00053439"},{"key":"10.1124\/jpet.108.136226_bib12","doi-asserted-by":"crossref","unstructured":"Gustafsson BI, Tommeras K, Nordrum I, Loennechen JP, Brunsvik A, Solligard E, Fossmark R, Bakke I, Syversen U, and Waldum H (2005) Long-term serotonin administration induces heart valve disease in rats. Circulation 111: 1517-1522.","DOI":"10.1161\/01.CIR.0000159356.42064.48"},{"key":"10.1124\/jpet.108.136226_bib13","doi-asserted-by":"crossref","unstructured":"Hoyer D, Hannon JP, and Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71: 533-554.","DOI":"10.1016\/S0091-3057(01)00746-8"},{"key":"10.1124\/jpet.108.136226_bib14","doi-asserted-by":"crossref","unstructured":"J\u00e4hnichen S, Glusa E, and Pertz HH (2005) Evidence for 5-HT2B and 5-HT7 receptor-mediated relaxation in pulmonary arteries of weaned pigs. Naunyn Schmiedebergs Arch Pharmacol 371: 89-98.","DOI":"10.1007\/s00210-004-1006-6"},{"key":"10.1124\/jpet.108.136226_bib15","doi-asserted-by":"crossref","unstructured":"Kaumann AJ and Levy FO (2006) 5-Hydroxytryptamine receptors in the human cardiovascular system. Pharmacol Ther 111: 67-706.","DOI":"10.1016\/j.pharmthera.2005.12.004"},{"key":"10.1124\/jpet.108.136226_bib16","doi-asserted-by":"crossref","unstructured":"King CM and Webb RC (1988) The endothelium partially obscures enhanced microvessel reactivity in DOCA hypertensive rats. Hypertension 12: 420-427.","DOI":"10.1161\/01.HYP.12.4.420"},{"key":"10.1124\/jpet.108.136226_bib17","doi-asserted-by":"crossref","unstructured":"Lazartigues E, Befel-Courbon C, Bagheri H, Costes S, Gharib C, Tran MA, Senard JM, and Montastruc JL (2000) Fluoxetine-induced pressor response in freely moving rats: a role for vasopressin and sympathetic tone. Fund Clin Pharmacol 14: 443-451.","DOI":"10.1111\/j.1472-8206.2000.tb00426.x"},{"key":"10.1124\/jpet.108.136226_bib18","doi-asserted-by":"crossref","unstructured":"McDuffie JE, Coaxum SD, and Maleque MA (1999) 5-Hydroxytryptamine evokes endothelial nitric oxide synthase activation in bovine aortic endothelial cell cultures. Proc Soc Exp Biol Med 221: 386-390.","DOI":"10.1046\/j.1525-1373.1999.d01-97.x"},{"key":"10.1124\/jpet.108.136226_bib19","doi-asserted-by":"crossref","unstructured":"McGregor DD and Smirk FH (1970) Vascular responses to 5-hydroxytryptamine in genetic and renal hypertensive rats. Am J Physiol 219: 687-690.","DOI":"10.1152\/ajplegacy.1970.219.3.687"},{"key":"10.1124\/jpet.108.136226_bib20","doi-asserted-by":"crossref","unstructured":"Nelson M, Coghlan JP, Denton DA, Tresham JJ, Whitworth JA, and Scoggins BA (1987) Ritanserin and serotonergic mechanisms in blood pressure and fluid regulation in sheep. Clin Exp Pharmacol Physiol 14: 555-563.","DOI":"10.1111\/j.1440-1681.1987.tb01874.x"},{"key":"10.1124\/jpet.108.136226_bib21","doi-asserted-by":"crossref","unstructured":"Nemecek GM, Coughlin SR, Handley DA, and Moskowitz MA (1986) Stimulation of aortic smooth muscle cell mitogenesis by serotonin. Proc Natl Acad Sci U S A 83: 674-678.","DOI":"10.1073\/pnas.83.3.674"},{"key":"10.1124\/jpet.108.136226_bib22","doi-asserted-by":"crossref","unstructured":"Ni W, Lookingland K, and Watts SW (2006) Arterial 5-hydroxytryptamine transporter function is impaired in deoxycorticosterone acetate and N-omega-l-arginine but not spontaneously hypertensive rats. Hypertension 48: 134-140.","DOI":"10.1161\/01.HYP.0000225754.15146.dd"},{"key":"10.1124\/jpet.108.136226_bib23","doi-asserted-by":"crossref","unstructured":"Ni W, Thompson JM, Northcott CA, Lookingland K, and Watts SW (2004) The serotonin transporter is present and functional in peripheral arterial smooth muscle. J Cardiovasc Pharmacol 43: 770-781.","DOI":"10.1097\/00005344-200406000-00006"},{"key":"10.1124\/jpet.108.136226_bib24","doi-asserted-by":"crossref","unstructured":"Ni W and Watts SW (2006) 5-Hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT). Clin Exp Pharmacol Physiol 33: 575-583.","DOI":"10.1111\/j.1440-1681.2006.04410.x"},{"key":"10.1124\/jpet.108.136226_bib25","doi-asserted-by":"crossref","unstructured":"Page IH and McCubbin JW (1953a) Modification of vascular responses to serotonin by drugs. Am J Physiol 174: 436-440.","DOI":"10.1152\/ajplegacy.1953.174.3.436"},{"key":"10.1124\/jpet.108.136226_bib26","doi-asserted-by":"crossref","unstructured":"Page IH and McCubbin JW (1953b) The variable arterial pressure response to serotonin in laboratory animals and man. Circ Res 1: 354-362.","DOI":"10.1161\/01.RES.1.4.354"},{"key":"10.1124\/jpet.108.136226_bib27","doi-asserted-by":"crossref","unstructured":"Rapport MM, Green AA, and Page IH (1948) Serum vasoconstrictor (serotonin): IV. Isolation and characterization. J Biol Chem 176: 1243-1251.","DOI":"10.1016\/S0021-9258(18)57137-4"},{"key":"10.1124\/jpet.108.136226_bib28","unstructured":"Richardson SM, Maleque MA, and Motley ED (2003) 3-Morpholinosyndnonimine inhibits 5-hydroxytryptamine-induced phosphorylation of nitric oxide synthase in endothelial cells. Cell Mol Biol 49: 1385-1389."},{"key":"10.1124\/jpet.108.136226_bib29","doi-asserted-by":"crossref","unstructured":"Russell A, Banes A, Berlin H, Fink GD, and Watts SW (2002) 5-Hydroxytryptamine2B receptor function is enhanced in the N-\u03c9-nitro-l-arginine hypertensive rat. J Pharmacol Exp Ther 303: 179-187.","DOI":"10.1124\/jpet.102.037390"},{"key":"10.1124\/jpet.108.136226_bib30","doi-asserted-by":"crossref","unstructured":"Saxena PR and Villalon CM (1990) Cardiovascular effects of serotonin agonists and antagonists. J Cardiovasc Pharmacol 15: S17-S34.","DOI":"10.1097\/00005344-199001001-00004"},{"key":"10.1124\/jpet.108.136226_bib31","doi-asserted-by":"crossref","unstructured":"Terr\u00f3n JA (1997) Role of 5-ht7 receptors in the long-lasting hypotensive response induced by 5-hydroxytryptamine in the rat. Br J Pharmacol 121: 563-571.","DOI":"10.1038\/sj.bjp.0701134"},{"key":"10.1124\/jpet.108.136226_bib32","doi-asserted-by":"crossref","unstructured":"Terr\u00f3n JA, Sanchez-Maldonado C, and Martinez-Garcia E (2007) Pharmacological evidence that 5-HT1B\/1D receptors mediate hypotension in anesthetized rats. Eur J Pharmacol 576: 132-135.","DOI":"10.1016\/j.ejphar.2007.08.005"},{"key":"10.1124\/jpet.108.136226_bib33","doi-asserted-by":"crossref","unstructured":"Villal\u00f3n CM and Centurion D (2007) Cardiovascular responses produced by 5-hydroxytryptamine: a pharmacological update on receptors\/mechanisms involved and therapeutic implications. Naunyn Schmiedebergs Arch Pharmacol 376: 45-63.","DOI":"10.1007\/s00210-007-0179-1"},{"key":"10.1124\/jpet.108.136226_bib34","doi-asserted-by":"crossref","unstructured":"Wang D-S, Xie H-H, Shen F-M, Cai G-J, and Su D-F (2005) Blood pressure variability, cardiac baroreflex sensitivity and organ damage in experimentally hypertensive rats. Clin Exp Pharmacol Physiol 32: 545-552.","DOI":"10.1111\/j.1440-1681.2005.04229.x"},{"key":"10.1124\/jpet.108.136226_bib35","doi-asserted-by":"crossref","unstructured":"Watts SW (2000) 5-Hydroxytryptamine-induced potentiation of endothelin-1- and norepinephrine-induced contraction is mitogen-activated protein kinase pathway dependent. Hypertension 35: 244-248.","DOI":"10.1161\/01.HYP.35.1.244"},{"key":"10.1124\/jpet.108.136226_bib36","doi-asserted-by":"crossref","unstructured":"Watts SW (2005) 5-HT in systemic hypertension; foe, friend or fantasy? Clin Sci 108: 399-412.","DOI":"10.1042\/CS20040364"},{"key":"10.1124\/jpet.108.136226_bib37","doi-asserted-by":"crossref","unstructured":"Watts SW and Fink GD (1999) 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats. Am J Physiol Heart Circ Physiol 276: H944-H952.","DOI":"10.1152\/ajpheart.1999.276.3.H944"},{"key":"10.1124\/jpet.108.136226_bib38","doi-asserted-by":"crossref","unstructured":"Xiao XH and Rand MJ (1989) Amplification by serotonin of responses to other vasoconstrictor agents in the rat tail artery. Clin Exp Pharmacol Physiol 16: 725-736.","DOI":"10.1111\/j.1440-1681.1989.tb01627.x"},{"key":"10.1124\/jpet.108.136226_bib39","doi-asserted-by":"crossref","unstructured":"Yildiz O, Smith JR, and Purdy RE (1998) Serotonin and vasoconstrictor synergism. Life Sci 62: 1723-1732.","DOI":"10.1016\/S0024-3205(97)01166-1"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524344787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524344787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.108.136226","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:39:36Z","timestamp":1740004776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524344787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0022356524344787"],"URL":"https:\/\/doi.org\/10.1124\/jpet.108.136226","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-Hydroxytryptamine Lowers Blood Pressure in Normotensive and Hypertensive Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.108.136226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}